November 2022

Regulatory Roundup: Updates on 2 recalls, a new heart valve & more | Nontraditional risk factors & AVR ()
Heart Rhythm Highlights: ACC, HRS respond to final MPFS | OAC use among older AFib patients | Treating VT storm ()
1 New TAVR system linked to key improvements | Radial artery grafts vs. saphenous vein grafts for CABG ()
One-year data on transcatheter tricuspid valve replacement | New research on salt intake & CVD ()
FDA approves world’s most expensive drug | AI uses Apple Watch data to ID heart disease | ADHD meds & CVD ()
'Good' cholesterol & CVD | Surgeons make history | A warning from the FDA | More from the last week ()
Key news, video and photos from AHA 2022 ()
New heart pump implanted for the first time in historic procedure | Catheter ablation & ventricular tachycardia storm ()
Structural Heart Disease Highlights: A historic valve-in-valve TAVR | AS screening | TEER & cardiogenic shock ()
Rethinking the link between ‘good’ cholesterol & heart disease | New video on the BEST-CLI trial | VR & cardiology ()
FDA issues warnings for illegally selling supplements | Telehealth for CVD | OAC use among older AFib patients ()
AS is undertreated & underdiagnosed | Fake tweet leads to chaos | Cryoablation & AFib | More from the last week ()
TAVR Highlights: Cardiologists make history | AS remains undertreated, underdiagnosed | 1-year mortality ()
How a fake tweet caused chaos for Eli Lilly & reignited the insulin debate | Flu shots boost health for HF patients ()
Heart Health Highlights: BP medication recalled | Coffee & CHD | New data on marijuana, meth, cocaine & opiates ()
Former surgeon general says cardiologists need to address hypertension, COVID | Etripamil nasal spray terminates PSVT ()
STEMI transfers need a new approach | Cryoablation as a front-line therapy | SPYRAL HTN-ON MED failed primary endpoint ()
AHA says aortic stenosis is undertreated and underdiagnosed | High copays lower PAH drug adherence | New ASE app ()
AHA Key takeaways | FDA Commissioner Robert Califf calls on cardiology to address inequities and misinformation ()
PRECISE shows CT/FFR-CT improves outcomes | Diet supplements do not improve LDL | Coffee may increase the heart disease ()
Why it may be time to rethink AFib treatments | New data on COVID-related myocarditis ()
Vascular & Endovascular Highlights: IVL in real-life PAD patients | DCBs & femoropopliteal disease ()
ACC's president discusses Medicare cuts | Coffee & CHD | Diabetes patients having fewer heart attacks, strokes ()
Interventional Cardiology Highlights: The FDA's busy month | Repeat surgery vs. PCI | Cordis to acquire MedAlliance ()
A closer look at the PRECISE trial | Evaluating the risk of heart damage associated with 2 COVID-19 vaccines ()
Heart Failure Highlights: A troubling trend | Key FDA approvals | Early ECMO | Dapagliflozin & AFib ()
AHA Scientific Sessions 2022: Dietary supplements & cholesterol | Surgery & CLTI | Early ECMO & cardiogenic shock ()
5 key takeaways from the ACC/AHA aortic disease guidelines | AI-powered CCTA vs. usual care for stable chest pain ()
J&J to acquire Abiomed | Repeat surgery vs. PCI | Surprising ECG data from pig heart transplant | More from the last week ()
Economics Highlights: The 2023 Medicare Physician Fee Schedule | J&J to acquire Abiomed in $16.6B deal ()
AI-powered ECG screening boosts outcomes | Predicting post-TAVR mortality ()
Cardiologists ‘disappointed’ in CMS | SYMPLICITY HTN-3 & the future of renal denervation | New IVL data ()
Care Delivery Highlights: ACC's new ASCVD recommendations | The value of FFR-guided PCI ()
October's 10 Biggest Stories: BP medication recalled | Cardiologists make history | Severe PPM & TAVR | Much more! ()
Surprising ECG data from pig heart transplant | Johnson & Johnson to acquire Abiomed in $16.6B deal ()
Breaking News: Johnson & Johnson to acquire Abiomed in $16.6B deal ()